Cerus Corp
NASDAQ:CERS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cerus Corp
NASDAQ:CERS
|
US |
|
Global Cord Blood Corp
OTC:CORBF
|
HK |
|
Virco Mfg Corp
NASDAQ:VIRC
|
US |
|
Y
|
Yara International ASA
DUS:IU2
|
NO |
|
Dassault Aviation SA
PAR:AM
|
FR |
|
N
|
Newcity (Bangkok) PCL
SET:NC
|
TH |
|
T
|
Talga Group Ltd
F:TGX
|
AU |
|
T
|
Techno Medical PCL
SET:TM
|
TH |
|
S
|
Super Energy Corporation PCL
SET:SUPER
|
TH |
Intrinsic Value
Is CERS undervalued or overvalued?
See the intrinsic value estimate for Cerus Corp and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
CERS looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with CERS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Cerus Does
Cerus Corp makes blood safety products that are used to treat donated blood before it goes to patients. Its main product is the INTERCEPT Blood System, which uses a chemical and light process to reduce the risk that viruses, bacteria, and other harmful pathogens in platelets, plasma, and some red blood cell products can be passed through transfusion. In simple terms, Cerus sells equipment and single-use treatment kits that help blood centers make donated blood safer.
- Headquarters
- United States of America US
- Employees
- 275
- IPO date
- Jan 31, 1997
Revenue & Expenses Breakdown
Cerus Corp
Earnings Waterfall
Cerus Corp
The intrinsic value for Cerus Corp (CERS) under the Base Case is hidden USD.
Compared with the current market price of 2.26 USD, the stock appears hidden.